The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...
Thomas Method said he entered the Capitol building but left within 10 minutes because he didn't know it was going to turn ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
Sisitsky submitted his plan to comply with the law late last month after city councilors voted to table discussing the issue until February.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback